Patients on Osteoporosis’ Medication May Develop Eye Disorder, Say Researchers

.

Patients on Osteoporosis’ Medication May Develop Eye Disorder, Say Researchers

For the very first time, a study has showed that patients on osteoporosis’ medication are at a higher risk of being affected with inflammatory eye disease. The study was conducted by the researchers of Child and Family Research Institute located in Vancouver.

During the study, the researchers examined the effect of osteoporosis’ medication, oral bisphosphonates over eye conditions uveitis and scleritis. During the study, it was found that the patients on bisphosphonates were at higher risk of developing the eye disorders.

The findings of the study have been published in the journal Canadian Medical Association. For the study, the researchers analyzed the data of 934,147 patients. The majority of the patients were not taking the bisphosphonates.

The researchers informed that patients who had been taking bisphosphonates for the very first time were more likely to be affected with uveitis and scleritis. The author of the study noted, “Our study highlights the need for clinicians to inform their patients about the signs and symptoms of scleritis and uveitis, so that prompt treatment may be sought and further complications averted”.

The findings have stirred unrest among the health experts, as it is for the very first time when a study has showed that the osteoporosis’ medication can have adverse outcomes on the health of the patients.


Latest News

Researchers Clone Stem Cells From Human Adults
Victorians donate $16.8 million to Good Friday Appeal
Impact of childhood bullying remains after 40 years
This will keep you happy
Bigwig German media firm Axel Springer’s CEO criticizes Google in open letter
Google launches e-mail notifications for Google Trends service
Groundbreaking operation experienced by Vicky the orangutan
Sleep positions say a lot about your relationship
Pet cat gives meningitis to kid
Bar set higher for foreign doctors to work in England
Nose can be a pathfinder
NPD: Xbox One and PS4 sales have surpassed 5 million and 7 million units respect